kymriah
novartis europharm limited - tisagenlecleucel - precursor b-cell lymphoblastic leukemia-lymphoma; lymphoma, large b-cell, diffuse - andere antineoplastische mittel - kymriah is indicated for the treatment of:• paediatric and young adult patients up to and including 25 years of age with b cell acute lymphoblastic leukaemia (all) that is refractory, in relapse post transplant or in second or later relapse. • adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl) after two or more lines of systemic therapy. • adult patients with relapsed or refractory follicular lymphoma (fl) after two or more lines of systemic therapy.
eremfat 600 mg
esteve pharmaceuticals gmbh (8146447) - rifampicin - filmtablette - teil 1 - filmtablette; rifampicin (02599) 600 milligramm
eremfat 450 mg
esteve pharmaceuticals gmbh (8146447) - rifampicin - filmtablette - teil 1 - filmtablette; rifampicin (02599) 450 milligramm
eremfat 300 mg
esteve pharmaceuticals gmbh (8146447) - rifampicin - filmtablette - teil 1 - filmtablette; rifampicin (02599) 300 milligramm
eremfat 150 mg
esteve pharmaceuticals gmbh (8146447) - rifampicin - filmtablette - teil 1 - filmtablette; rifampicin (02599) 150 milligramm
rifampicin eberth 600 mg pulver zur herstellung einer infusionslösung
dr. friedrich eberth arzneimittel gmbh (4238106) - rifampicin - pulver zur herstellung einer infusionslösung - 600 mg - rifampicin (02599) 600 milligramm
rifampicin eberth 300 mg pulver zur herstellung einer infusionslösung
dr. friedrich eberth arzneimittel gmbh (4238106) - rifampicin - pulver zur herstellung einer infusionslösung - 300 mg - rifampicin (02599) 300 milligramm